Los puntos clave no están disponibles para este artículo en este momento.
Our results identified AATD mutations as a genetic-based contributor to lung disease in patients with COPD or bronchiectasis and assessed their frequency in a population of Turkish patients.
Önür et al. (Wed,) studied this question.